Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2654 |
|
| Actual shortage: | 249 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2396 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
29 (12%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| AERMONY RESPICLICK | 55MCG | POWDER (METERED DOSE) | Resolved | 2022-12-01 | 2023-01-18 | 176791 |
| TEVA-NAPROXEN SODIUM DS | 550MG | TABLET | Resolved | 2020-04-03 | 2020-04-09 | 110752 |
| TEVA-NAPROXEN SODIUM DS | 550MG | TABLET | Resolved | 2020-06-25 | 2020-07-23 | 118954 |
| TEVA-NAPROXEN SODIUM DS | 550MG | TABLET | Resolved | 2021-01-22 | 2021-03-18 | 132257 |
| TEVA-NAPROXEN SODIUM DS | 550MG | TABLET | Resolved | 2022-05-05 | 2022-06-04 | 160072 |
| TEVA-NAPROXEN SODIUM DS | 550MG | TABLET | Resolved | 2023-10-19 | 2023-11-09 | 207509 |
| TEVA-METHYLPHENIDATE ER-C | 54MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2017-11-24 | 2020-01-21 | 30691 |
| ACT METHYLPHENIDATE ER | 54MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-11-01 | 2024-02-13 | 65999 |
| NOVO-HYDROXYZIN | 50MG | CAPSULE | Actual shortage | 2017-03-13 | 2020-02-13 | 1017 |
| TEVA-QUETIAPINE XR | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-13 | 2017-10-10 | 1778 |
| TEVA-ATENOLOL | 50MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1797 |
| TEVA-AMITRIPTYLINE | 50MG | TABLET | Resolved | 2017-03-14 | 2017-05-23 | 2434 |
| TEVA-AMITRIPTYLINE | 50MG | TABLET | Resolved | 2017-03-14 | 2017-05-23 | 2437 |
| TEVA-BICALUTAMIDE | 50MG | TABLET | Resolved | 2017-04-03 | 2017-05-10 | 5174 |
| TEVA-BICALUTAMIDE | 50MG | TABLET | Resolved | 2017-11-16 | 2018-03-13 | 29450 |
| TEVA-FLUVOXAMINE | 50MG | TABLET | Resolved | 2018-02-21 | 2019-05-28 | 40417 |
| TEVA-QUETIAPINE XR | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-03-16 | 2018-05-30 | 43168 |
| TEVA-METOPROLOL | 50MG | TABLET | Resolved | 2019-06-18 | 2019-07-15 | 86896 |
| TEVA-METOPROLOL | 50MG | TABLET | Resolved | 2019-06-18 | 2019-07-15 | 86899 |
| TEVA-BICALUTAMIDE | 50MG | TABLET | Resolved | 2019-06-18 | 2019-08-06 | 86960 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81337 | ||
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81344 | ||
| HYDROCORTISONE SODIUM SUCCINATE INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81347 | ||
| TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106136 | ||
| TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106139 | ||
| RATIO-SALBUTAMOL | Discontinued | 2020-02-13 | 2020-02-13 | 106151 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106155 | ||
| EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106170 | ||
| LINEZOLID INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106173 | ||
| EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106176 |